Evaluation and treatment of fever in the non-neutropenic child with cancer

Journal of Pediatric Hematology/Oncology

Volumn 25, Issue 8, 2003, Pages 606-612

  Salzer, Wanda ^a,c   Steinberg, Seth M ^b   Liewehr, David J ^b   Freifeld, Alison ^a,d   Balis, Frank M ^a   Widemann, Brigitte C ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c USAF Medical Center Keesler   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Cancer; Children; Fever; Non neutropenia; Treatment

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN;

ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; CANCER PATIENT; CELL COUNT; CENTRAL VENOUS CATHETER; CHILDHOOD CANCER; CLINICAL PRACTICE; DIAGNOSTIC APPROACH ROUTE; FEVER; HOSPITAL ADMISSION; HUMAN; MEDICAL SOCIETY; NEUTROPENIA; NEUTROPHIL; PRIORITY JOURNAL; QUESTIONNAIRE;

ANTI-BACTERIAL AGENTS; CHILD; FEVER; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HUMANS; NEOPLASMS; PEDIATRICS; PRACTICE GUIDELINES;

EID: 0042069781     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200308000-00004     Document Type: Article

References (29)

1. Santolaya M, Alvarez A, Becker A, et al. Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. J Clin Oncol. 2001;19:3415-3421.
2. Mustafa MM, Aquino V, Pappo A, et al. A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia. J Pediatr. 1996;128:847-849.
3. Cohen KJ, Leamer K, Odom L, et al. Cessation of antibiotics regardless of ANC is safe in children with febrile neutropenia. A preliminary prospective trial. J Pediatr Hematol Oncol. 1995;17:325-330.
4. Griffin TC, Buchanan G. Hematologic predictors of bone marrow recovery in neutropenic patients hospitalized for fever: implications for discontinuation of antibiotics and early discharge from the hospital. J Pediatr. 1992;121:28-33.
5. Bash RO, Katz J, Cash J, et al. Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia. Cancer. 1994;74:189-196.
6. Mullen CA, Buchanan G. Early hospital discharge of children with cancer treated for fever and neutropenia: identification and management of the low-risk patient. J Clin Oncol. 1990;8:1998-2004.
7. Jones GR, Konsler G, Dunaway R, et al. Risk factors for recurrent fever after the discontinuation of empiric antibiotic therapy for fever and neutropenia in pediatric patients with a malignancy or hematologic condition. J Pediatr. 1994;124:703-708.
8. Freifeld AG, Pizzo P. The outpatient management of febrile neutropenia in cancer patients. Oncology (Huntingt). 1996;10:599-615.
9. Aquino VM, Tkaczewski I, Buchanan GR. Early discharge of low-risk febrile neutropenic children and adolescents with cancer. Clin Infect Dis. 1997;25:74-78.
10. Aquino VM, Buchanan GR, Tkaczewski I, et al. Safety of early hospital discharge of selected febrile children and adolescents with cancer with prolonged neutropenia. Med Pediatr Oncol. 1997;28:191-195.
11. Klaassen RJ, Goodman TR, Pham B, et al. Low-risk prediction rule for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol. 2000;18:1012-1019.
12. Rackoff WR, Gonin R, Robinson C, et al. Predicting the risk of bacteremia in childen with fever and neutropenia. J Clin Oncol. 1996;14:919-924.
13. Alexander S, Walsh T, Freifeld A, et al. Infectious complications in the pediatric cancer patient. In: Pizzo P, Poplack D, eds. Principles and Practice of Pediatric Oncology: Philadelphia: Lippincott Williams & Wilkins, 2002:1243-1244.
14. Adamkiewicz T, Lorenzana A, Doyle J, et al. Peripheral vs. central blood cultures in patients admitted to a pediatric oncology ward. Pediatr Infect Dis J. 1999;18:556-558.
15. Gorelick MH, Owen W, Seibel N, et al. Lack of association between neutropenia and the incidence of bacteremia associated with indwelling central venous catheters in febrile pediatric cancer patients. Pediatr Infect Dis J. 1991;10:506-510.
16. Rahiala J, Perkkio M, Riikonen P. Infections occurring during the courses of anticancer chemotherapy in children with ALL: a retrospective analysis of 59 patients. Pediatr Hematol Oncol. 1998;15:165-174.
17. McNemar Q. Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika. 1947;12:153-157.
18. Lehmann E. Nonparametrics: Statistical Methods Based on Ranks: San Francisco: Holden-Day, 1975.
19. Sandoval C, Giamelli J, Visintainer P, et al. Management of febrile non-neutropenic episodes in pediatric oncology patients. J Pediatr Hematol Oncol. 1998;20:374.
20. Aledo A, Heller G, Ren L, et al. Septicemia and septic shock in pediatric patients: 140 consecutive cases on a pediatric hematology-oncology service. J Pediatr Hematol Oncol. 1998;20:215-221.
21. Petrilli A, Dantas L, Campos M, et al. Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial. Med Pediatr Oncol. 2000;34:87-91.
22. Mullen C, Petropoulos D, Roberts W, et al. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients. Cancer. 1999;86:126-134.
23. Lau R, Doyle J, Freedman M, et al. Early discharge of pediatric febrile neutropenic cancer patients by substitution of oral for intravenous antibiotics. Pediatr Hematol Oncol. 1994;11:417-421.
24. Aquino V, Herrera L, Sandler E, et al. Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer. Cancer. 2000;88:1710-1714.
25. Grady K, Wallston B. Selecting the sample. In: Bickman L, Rog D, eds. Research in Health Care Settings: Newbury Park: SAGE Publications, 1988:66-83.
26. Cummings SM, Savitz LA, Konrad TR. Reported response rates to mailed physician questionnaires. Health Serv Res. 2001;35:1347-1355.
27. Halpern SD, Ubel PA, Berlin JA, et al. Randomized trial of 5 dollars versus 10 dollars monetary incentives, envelope size, and candy to increase physician response rates to mailed questionnaires. Med Care. 2002;40:834-839.
28. Kellerman SE, Herold J. Physician response to surveys. A review of the literature. Am J Prev Med. 2001;20:61-67.
29. Pizzo PA, Robichaud KJ, Gill FA, et al. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med. 1982;72:101-111.